Vicore Pharma Holding AB (publ) (STO:VICO)
Sweden
· Delayed Price · Currency is SEK 7.12
-0.11 (-1.52%)
Mar 31, 2025, 2:59 PM CET
Vicore Pharma Holding AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 1,156 | 333.62 | 256.8 | 294.2 | 248.62 | Upgrade
|
| Short-Term Investments | - | 149.15 | 4.94 | 77.28 | 70.12 | Upgrade
|
| Cash & Short-Term Investments | 1,156 | 482.77 | 261.74 | 371.48 | 318.74 | Upgrade
|
| Cash Growth | 139.45% | 84.44% | -29.54% | 16.55% | 20.45% | Upgrade
|
| Other Receivables | 14.39 | 3.13 | 2.18 | 1.42 | 8.51 | Upgrade
|
| Receivables | 14.39 | 3.13 | 2.18 | 1.42 | 8.51 | Upgrade
|
| Prepaid Expenses | 32.72 | 9.7 | 5.87 | 5.03 | 0.61 | Upgrade
|
| Total Current Assets | 1,203 | 495.6 | 269.79 | 377.93 | 327.85 | Upgrade
|
| Property, Plant & Equipment | - | 0.03 | 0.12 | 0.4 | 0.25 | Upgrade
|
| Long-Term Investments | - | - | - | 5.41 | 7.53 | Upgrade
|
| Other Intangible Assets | - | 2.22 | 68.1 | 67.43 | 70.76 | Upgrade
|
| Long-Term Deferred Tax Assets | - | - | - | - | 0.13 | Upgrade
|
| Total Assets | 1,203 | 497.84 | 338.01 | 451.17 | 406.52 | Upgrade
|
| Accounts Payable | 29.97 | 17.92 | 23.5 | 23.98 | 10.94 | Upgrade
|
| Accrued Expenses | 22.97 | 14.65 | 18.22 | 40.14 | 29.53 | Upgrade
|
| Current Portion of Leases | - | - | 0.07 | - | 0.14 | Upgrade
|
| Current Income Taxes Payable | 1.93 | 1.13 | 0.76 | 0.34 | 0.55 | Upgrade
|
| Other Current Liabilities | 18.04 | 7.27 | 3.88 | 1.26 | 6.92 | Upgrade
|
| Total Current Liabilities | 72.91 | 40.96 | 46.42 | 65.72 | 48.09 | Upgrade
|
| Long-Term Leases | - | - | - | 0.32 | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | 0.32 | 0.59 | 0.91 | 1.21 | 1.53 | Upgrade
|
| Other Long-Term Liabilities | 0.56 | 0.9 | 1.6 | 0.6 | 2.39 | Upgrade
|
| Total Liabilities | 73.78 | 42.45 | 48.92 | 67.85 | 52 | Upgrade
|
| Common Stock | 117.29 | 55.86 | 40.92 | 35.88 | 30.21 | Upgrade
|
| Additional Paid-In Capital | - | 1,674 | 1,211 | 1,022 | 702.05 | Upgrade
|
| Retained Earnings | - | -1,274 | -962.65 | -674.23 | -377.75 | Upgrade
|
| Comprehensive Income & Other | 1,012 | - | - | - | - | Upgrade
|
| Shareholders' Equity | 1,129 | 455.39 | 289.08 | 383.32 | 354.51 | Upgrade
|
| Total Liabilities & Equity | 1,203 | 497.84 | 338.01 | 451.17 | 406.52 | Upgrade
|
| Total Debt | - | - | 0.07 | 0.32 | 0.14 | Upgrade
|
| Net Cash (Debt) | 1,156 | 482.77 | 261.68 | 371.16 | 318.6 | Upgrade
|
| Net Cash Growth | 139.45% | 84.49% | -29.50% | 16.50% | 20.49% | Upgrade
|
| Net Cash Per Share | 8.39 | 5.00 | 3.62 | 5.33 | 5.87 | Upgrade
|
| Filing Date Shares Outstanding | 234.58 | 111.72 | 81.85 | 71.76 | 71.76 | Upgrade
|
| Total Common Shares Outstanding | 234.58 | 111.72 | 81.85 | 71.76 | 60.42 | Upgrade
|
| Working Capital | 1,130 | 454.64 | 223.37 | 312.21 | 279.76 | Upgrade
|
| Book Value Per Share | 4.81 | 4.08 | 3.53 | 5.34 | 5.87 | Upgrade
|
| Tangible Book Value | 1,129 | 453.17 | 220.98 | 315.89 | 283.76 | Upgrade
|
| Tangible Book Value Per Share | 4.81 | 4.06 | 2.70 | 4.40 | 4.70 | Upgrade
|
| Machinery | - | 0.15 | 0.15 | 0.15 | 0.15 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.